M. Nosrati

Trans Fatty Acid Content of Iranian Edible Oils

B. Jannat, N. Sadeghi, M. Oveisi, 2013 .

A scoping review on patient heterogeneity in economic evaluations of precision medicine based on basket trials

S. Nikfar, M. Hasanzad, M. Nosrati, 2022, Expert review of pharmacoeconomics & outcomes research.

Cost-utility analysis of Macitentan Vs. Bosentan in pulmonary atrial hypertension

H. Hamedifar, H. Rouhani, M. Afzali, 2020, Journal of family medicine and primary care.

A cost minimization analysis of Azelastine/Fluticasone combination nasal spray versus Azelastine and Fluticasone nasal sprays monotherapy in moderate to severe allergic rhinitis in Iran

S. Nikfar, D. Babaie, N. Ayati, 2017 .

Impact of Protocol Implementation on Rationalization of Albumin Use in a Tertiary Care Teaching Hospital in Tehran, Iran

H. Mahmoodzadeh, K. Gholami, S. Ebrahimpour, 2018, Journal of research in pharmacy practice.

Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice

K. Gholami, N. Saadat, S. Najafi, 2018, International Journal of Clinical Pharmacy.

Effect of a Community Pharmacist–Delivered Diabetes Support Program for Patients Receiving Specialty Medical Care

A. Rashidian, K. Gholami, N. Saadat, 2015, The Diabetes educator.

Pharmacoeconomic evaluation of insulin aspart and glargine in type 1 and 2 diabetes mellitus in Iran

S. Nikfar, P. Saiyarsarai, M. Nosrati, 2023, Journal of Diabetes & Metabolic Disorders.

A cost-effectiveness analysis of linagliptin add-on to insulin treatment for patients with type 2 diabetes mellitus and chronic kidney disease in Iran

S. Nikfar, M. Nosrati, Soroush Fariman, 2023, Journal of Diabetes & Metabolic Disorders.